| 18-Jun-13 08:11AM | Dara BioSciences grants T3D Therapeutics worldwide rights to commercialize DB959 theflyonthewall.com |
| 08:02AM | InPlay: DARA BioSciences grants T3D therapeutics exclusive worldwide rights to develop and commercialize DB959 Briefing.com |
| 08:01AM | DARA BioSciences Grants T3D Therapeutics Exclusive Worldwide Rights to Develop and Commercialize DB959 Marketwired |
| 01:31AM | DARA BIOSCIENCES, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online |
| 03-Jun-13 07:32AM | DARA Biosciences Enrolls Leading Oncology Centers in Breast Cancer Patient Registry Marketwired |
| 07:32AM | DARA Biosciences Enrolls Leading Oncology Centers in Breast Cancer Patient Registry Marketwire |
| 23-May-13 01:04PM | DARA BIOSCIENCES, INC. Financials EDGAR Online Financials |
| 16-May-13 11:30AM | Slow Q1 Doesn't Derail DARA Thesis Zacks Small Cap Research |
| 15-May-13 04:49PM | DARA Reports First Quarter 2013 Financial Results and Operational Highlights Marketwired |
| 04:49PM | DARA Reports First Quarter 2013 Financial Results and Operational Highlights Marketwire |
| 09:04AM | DARA BIOSCIENCES, INC. Files SEC form 10-Q, Quarterly Report EDGAR Online |
| 14-May-13 09:43AM | DARA BIOSCIENCES, INC. Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Stan EDGAR Online |
| 22-Apr-13 08:30AM | InPlay: DARA BioSciences and HELSINN announce U.S. launch of Gelclair, an FDA-cleared oral gel for the treatment of oral mucositis Briefing.com +5.48% |
| 08:30AM | DARA and HELSINN Announce U.S. Launch of Gelclair(R), an FDA-Cleared Oral Gel for the Treatment of Oral Mucositis Marketwired |
| 08:30AM | DARA and HELSINN Announce U.S. Launch of Gelclair(R), an FDA-Cleared Oral Gel for the Treatment of Oral Mucositis Marketwire |
| 11-Apr-13 07:34AM | Dara Biosciences: Don't Believe The Hype Surrounding This Biopharma at Seeking Alpha |
| 10-Apr-13 10:17AM | DARA Bio: A Vastly Undervalued Emerging Story at Seeking Alpha |
| 03-Apr-13 03:57PM | 4 Healthcare Stock Stories For Midweek Perusal at Wall St. Cheat Sheet |
| 01:04PM | DARA BIOSCIENCES, INC. Financials EDGAR Online Financials |
| 08:03AM | InPlay: DARA BioSciences enters into distribution agreement for Gelclair and Soltamox with Prime Therapeutics Specialty Pharmacy Briefing.com |
| 08:00AM | DARA BioSciences Enters Into Distribution Agreement for Gelclair(R) and Soltamox(R) With Prime Therapeutics Specialty Pharmacy Marketwired |
| 08:00AM | DARA BioSciences Enters Into Distribution Agreement for Gelclair(R) and Soltamox(R) With Prime Therapeutics Specialty Pharmacy Marketwire |
| 02-Apr-13 08:52AM | The Week Ahead Could Be Pivotal For These Small Cap Companies' Stocks at Seeking Alpha |
| 01-Apr-13 09:17AM | DARA BIOSCIENCES, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Ex EDGAR Online |
| 08:00AM | DARA Reports Year-End 2012 Financial Results Marketwired |
| 08:00AM | DARA Reports Year-End 2012 Financial Results Marketwire |
| 28-Mar-13 09:13AM | DARA BIOSCIENCES, INC. Files SEC form 10-K, Annual Report EDGAR Online |
| 22-Mar-13 10:01AM | Nuvilex: A Penny Stock That Could Be A Disease-Fighting Game Changer at Seeking Alpha |
| 18-Mar-13 08:00AM | DARA BioSciences to Present at 25th Annual ROTH Conference Marketwired |
| 08:00AM | DARA BioSciences to Present at 25th Annual ROTH Conference Marketwire |
| 13-Mar-13 08:20AM | New Programs Designed to Speed Up Approval Process a Key Factor in Biotech Industry's Growth in 2012 Marketwired |
| 08:20AM | New Programs Designed to Speed Up Approval Process a Key Factor in Biotech Industry's Growth in 2012 Marketwire |
| 06-Mar-13 05:28AM | Biotech Stocks With Recent Developments: 3 To Consider, 1 To Avoid at Seeking Alpha |
| 05-Mar-13 04:07PM | DARA BIOSCIENCES, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibi EDGAR Online |
| 01-Mar-13 07:03AM | InPlay: DARA BioSciences appoints Haywood Cochrane as Chairman of the Board Briefing.com |
| 07:00AM | DARA BioSciences Appoints Haywood Cochrane Jr. as Chairman of the Board of Directors and Names Paul Richardson as a New Board Member Marketwire |
| 20-Feb-13 08:05AM | Upcoming Catalysts For These BioPharmas Provide Potential Upside at Seeking Alpha -6.09% |
| 19-Feb-13 08:20AM | U.S. Food and Drug Administration Approved 30% More Drugs in 2012 Than the Year Previous Marketwire |
| 08:06AM | Orphan Drug Catalyst Pushing DARA Shares Toward Possible Technical Break-Out Marketwire |
| 14-Feb-13 08:00AM | InPlay: DARA BioSciences regains compliance with NASDAQ $1.00 minimum bid price rule Briefing.com +10.58% |
| 08:00AM | DARA BioSciences Regains Compliance with NASDAQ $1.00 Minimum Bid Price Rule Business Wire |
| 11-Feb-13 08:30AM | DARA BioSciences to Present at 15th Annual BIO CEO & Investor Conference Business Wire |
| 05-Feb-13 10:38AM | Dara BioSciences: A Catalyst Primer at Seeking Alpha |
| 07:20AM | Imminent Catalysts Should Keep Investor Interest Alive For Dara BioSciences at Seeking Alpha |
| 25-Jan-13 08:20AM | Merger and Acquisition Activity Expected to Rise in 2013 as Big Pharma Companies Flush With Cash Marketwire +8.70% |
| 24-Jan-13 12:36PM | 5 Stocks Under $10 Poised to Pop at TheStreet +6.98% |
| 11-Jan-13 05:56PM | Noble Financial January 22-23 Equity Conference Attracts More Than 100 Public Companies Marketwire |
| 08-Jan-13 08:00AM | DARA BioSciences to Present at the 6th Annual OneMedForum Conference Business Wire |
| 31-Dec-12 02:56PM | Quest Diagnostics Unafraid of the SCOTUS, Stryker Investigated in Poland: Healthcare Business Recap at Wall St. Cheat Sheet |
| 08:47AM | DARA BIOSCIENCES, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of Equity Se EDGAR Online |
| 08:31AM | InPlay: DARA BioSciences to raise $2.8 mln pursuant to securities purchase agreement; funds earmarked for Soltamox commercial activities, Gelclair launch and working capital Briefing.com |
| 08:30AM | DARA BioSciences to Raise $2.8 Million Pursuant to Securities Purchase Agreement Business Wire |
| 06-Dec-12 04:05PM | DARA BIOSCIENCES, INC. Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Stan EDGAR Online |
| 04-Dec-12 04:27AM | DARA Biosciences Seeks Orphan Drug Status For KRN5500 at Seeking Alpha +6.02% |
| 03-Dec-12 04:58PM | Dara: The Future Of Oncology BioPharma On The Cheap at Seeking Alpha |
| 30-Nov-12 08:21AM | Improving Trend in FDA First Cycle Review Approvals a Major Factor for Biotech Industry's Success in 2012 Marketwire |
| 08:20AM | Improving Trend in FDA First Cycle Review Approvals a Major Factor for Biotech Industry's Success in 2012 Marketwire |
| 29-Nov-12 10:47AM | Orphan Drug Status Potentially Huge For DARA Bio at Seeking Alpha +17.81% |
| 08:07AM | InPlay: DARA BioSciences announces submission of KRN5500 to FDA for Orphan Design Briefing.com |
| 08:00AM | DARA BioSciences Announces Submission of KRN5500 to FDA for Orphan Designation Business Wire |
| 21-Nov-12 01:04PM | DARA BIOSCIENCES, INC. Financials EDGAR Online Financials |
| 16-Nov-12 01:32PM | Chemtura Initiated at Buy and 3 Analyst-Initiated Shares to Note at Wall St. Cheat Sheet +15.71% |
| 06:00AM | Exclusive Video Interviews With CEOs Now Available on Equities.com GlobeNewswire |
| 01:51AM | Coverage initiated on DARA BioSciences by Ladenburg Thalmann Briefing.com |
| 14-Nov-12 05:43PM | DARA BioSciences Reports Financial Results for the Third Quarter 2012 Business Wire |
| 04:09PM | DARA BIOSCIENCES, INC. Files SEC form 10-Q, Quarterly Report EDGAR Online |
| 12-Nov-12 09:00AM | DARA BioSciences Will Present at NYSSA Investing in Life Sciences Conference, November 29 Business Wire |
| 29-Oct-12 03:00PM | DARA BioSciences Will Present at Singular Research Conference November 1 Business Wire |
| 22-Oct-12 10:45AM | PropThink: A Pivotal Time for DARA with Commercial Launches, NASDAQ Compliance, and Investor Interest Thomson Reuters ONE |
| 09:31AM | InPlay: DARA BioSciences: New breast cancer drug option may impact patients who can't swallow pills; Avella Specialty Pharmacy reaches agreement to distribute Soltamox Briefing.com |
| 09:30AM | New Breast Cancer Drug Option May Impact Patients Who Can't Swallow Pills GlobeNewswire |
| 06:30AM | DARA BioSciences Launches Soltamox®, First and Only Liquid Version of Tamoxifen Citrate Business Wire |
| 06:30AM | DARA BioSciences Announces the U.S. Launch of Soltamox® Business Wire |
| 02-Oct-12 04:40PM | Dara Biosciences regains Nasdaq price compliance AP |
| 02:32PM | Einhorn Praises Cigna and 4 Healthcare Stocks Making Headlines Now at Wall St. Cheat Sheet |
| 01:54PM | Einhorn Praises Cigna and 4 Healthcare Stocks Making Headlines Now at Wall St. Cheat Sheet |
| 08:04AM | DARA BIOSCIENCES, INC. Files SEC form 8-K, Regulation FD Disclosure EDGAR Online |
| 06:32AM | InPlay: DARA BioSciences regains compliance with NASDAQ $1.00 minimum bid price rule; no longer contemplating a reverse stock split Briefing.com |
| 06:30AM | DARA BioSciences Regains Compliance with NASDAQ $1.00 Minimum Bid Price Rule Business Wire |
| 27-Sep-12 08:01AM | DARA BIOSCIENCES, INC. Files SEC form 8-K, Regulation FD Disclosure EDGAR Online |
| 26-Sep-12 07:45AM | Healthcare Business Review: Healthcare Realtys Secondary Offering, Daras New Deals at Wall St. Cheat Sheet -5.22% |
| 03:37AM | Healthcare Business Recap: Healthcare Realtys Secondary Offering, Daras New Deals at Wall St. Cheat Sheet |
| 25-Sep-12 05:30PM | Healthcare Business Recap: Healthcare Realtys Secondary Offering, Daras New Deals at Wall St. Cheat Sheet +6.48% |
| 03:00PM | Healthcare Review: DARA Biosciences , Genetic Technologies, Peregrine Pharmaceuticals Are Among Top Movers Thomson Reuters ONE |
| 07:00AM | DARA BioSciences Establishes Vertically Integrated Commercial Platform for Specialty Oncology Care and Support Products Business Wire |
| 19-Sep-12 06:11PM | Nasdaq stocks posting largest volume increases AP |
| 18-Sep-12 06:03PM | Nasdaq stocks posting largest volume increases AP +20.95% |
| 17-Sep-12 06:02PM | Nasdaq stocks posting largest volume increases AP |
| 01:11PM | 3 Best Biotech Stocks For This Week (Part II) at Seeking Alpha |
| 08:36AM | DARA BIOSCIENCES, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement EDGAR Online |
| 15-Sep-12 06:38AM | Healthcare Business Review: LOreals FDA WARNING, Daras SWISS Deal at Wall St. Cheat Sheet |
| 14-Sep-12 06:17PM | Nasdaq stocks posting largest volume increases AP +25.29% |
| 06:04PM | Healthcare Business Review: LOreals FDA WARNING, Daras SWISS Deal at Wall St. Cheat Sheet |
| 02:43AM | Time To Buy DARA Bio at Seeking Alpha |
| 13-Sep-12 06:09PM | Nasdaq stocks posting largest volume increases AP +8.75% |
| 02:24PM | 3 Stocks Under $5 Moving Higher at TheStreet |
| 08:33AM | InPlay: DARA BioSciences: The Helsinn Group of Switzerland announced that it has entered into an exclusive agreement with DARA Briefing.com |
| 08:30AM | Helsinn Grants to DARA Exclusive U.S. Commercial Rights to Gelclair®, an FDA-Cleared Oral Gel for the Treatment of Oral Mucositis Business Wire |
| 30-Aug-12 11:44AM | 5 Stocks Under $10 Set to Soar Higher at TheStreet -7.32% |
| 23-Aug-12 06:14PM | DARA Biosciences Inks Deal Zacks |
